Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Apply
Cetuximab & Pembrolizumab
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step